Functional connectivity as a means to delineate differences between treatment-resistant and treatment-responsive schizophrenia
- PMID: 26763784
- PMCID: PMC4969391
- DOI: 10.1152/jn.01127.2015
Functional connectivity as a means to delineate differences between treatment-resistant and treatment-responsive schizophrenia
Abstract
It has been estimated that one-third of schizophrenia patients are treatment resistant (TRS). Recent studies have shown that functional connectivity (FC) can be used for measuring connections between brain regions in diseased states. White, Wigton, Joyce, Collier, Fornito, and Shergill (Neuropsychopharmacology First published September 9, 2015; doi:10.1038/npp.2015.277) used FC to identify differences between schizophrenia patients responding to antipsychotic treatment and TRS patients. Their results support the idea that the groups differ not only in treatment response but also neurophysiologically through differences in FC.
Keywords: functional connectivity; nigrostriatal; schizophrenia; treatment resistant.
Copyright © 2016 the American Physiological Society.
Figures
Similar articles
-
Risk and resilience brain networks in treatment-resistant schizophrenia.Schizophr Res. 2018 Mar;193:284-292. doi: 10.1016/j.schres.2017.07.014. Epub 2017 Jul 21. Schizophr Res. 2018. PMID: 28735641
-
Resting-state functional connectivity in treatment response and resistance in schizophrenia: A systematic review.Schizophr Res. 2019 Sep;211:10-20. doi: 10.1016/j.schres.2019.07.020. Epub 2019 Jul 19. Schizophr Res. 2019. PMID: 31331784
-
Aberrant intra-salience network dynamic functional connectivity impairs large-scale network interactions in schizophrenia.Neuropsychologia. 2016 Dec;93(Pt A):262-270. doi: 10.1016/j.neuropsychologia.2016.11.003. Epub 2016 Nov 5. Neuropsychologia. 2016. PMID: 27825906
-
Olanzapine modulation of long- and short-range functional connectivity in the resting brain in a sample of patients with schizophrenia.Eur Neuropsychopharmacol. 2017 Jan;27(1):48-58. doi: 10.1016/j.euroneuro.2016.11.002. Epub 2016 Nov 23. Eur Neuropsychopharmacol. 2017. PMID: 27887859
-
Functional neuroimaging in treatment resistant schizophrenia: A systematic review.Neurosci Biobehav Rev. 2019 Sep;104:178-190. doi: 10.1016/j.neubiorev.2019.07.001. Epub 2019 Jul 2. Neurosci Biobehav Rev. 2019. PMID: 31276716
Cited by
-
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates.Front Pharmacol. 2019 Apr 16;10:402. doi: 10.3389/fphar.2019.00402. eCollection 2019. Front Pharmacol. 2019. PMID: 31040787 Free PMC article. Review.
-
Treatment-resistant schizophrenia: How far have we traveled?Front Psychiatry. 2022 Aug 30;13:994425. doi: 10.3389/fpsyt.2022.994425. eCollection 2022. Front Psychiatry. 2022. PMID: 36111312 Free PMC article.
-
Aberrant connectivity in the hippocampus, bilateral insula and temporal poles precedes treatment resistance in first-episode psychosis: a prospective resting-state functional magnetic resonance imaging study with connectivity concordance mapping.Brain Commun. 2024 May 4;6(3):fcae094. doi: 10.1093/braincomms/fcae094. eCollection 2024. Brain Commun. 2024. PMID: 38707706 Free PMC article.
-
Neural substrate of unrelenting negative symptoms in schizophrenia: a longitudinal resting-state fMRI study.Eur Arch Psychiatry Clin Neurosci. 2018 Oct;268(7):641-651. doi: 10.1007/s00406-017-0851-5. Epub 2017 Nov 11. Eur Arch Psychiatry Clin Neurosci. 2018. PMID: 29128871
-
Abnormal Fractional Amplitude of Low-Frequency Fluctuation as a Potential Imaging Biomarker for First-Episode Major Depressive Disorder: A Resting-State fMRI Study and Support Vector Machine Analysis.Front Neurol. 2021 Nov 29;12:751400. doi: 10.3389/fneur.2021.751400. eCollection 2021. Front Neurol. 2021. PMID: 34912284 Free PMC article.
References
-
- Alonso-Solis A, Vives-Gilabert Y, Grasa E, Portella MJ, Rabella M, Sauras RB, Roldán A, Núñez-Marín F, Gómez-Ansón B, Pérez V, Alvarez E, Corripio I. Resting-state functional connectivity alterations in the default network of schizophrenia patients with persistent auditory verbal hallucinations. Schizophr Res 161: 261–268, 2015. - PubMed
-
- Elkis H. Treatment-resistant schizophrenia. Psychiatr Clin North Am 30: 511–533, 2007. - PubMed
-
- Fornito A, Harrison BJ, Goodby E, Dean A, Ooi C, Nathan PJ, Lennox BR, Jones PB, Suckling J, Bullmore ET. Functional dysconnectivity of corticostriatal circuitry as a risk phenotype for psychosis. JAMA Psychiatry 70: 1143–1151, 2013. - PubMed
-
- Garrity AG, Pearlson GD, McKiernan K, Lloyd D, Kiehl KA, Calhoun VD. Aberrant “default mode” functional connectivity in schizophrenia. Am J Psychiatry 164: 450–457, 2007. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical